Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 197

1.

Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart.

Necchi A, Bratslavsky G, Chung J, Millis S, Gay LM, Ali SM, Ross JS.

Oncologist. 2019 Jan 18. pii: theoncologist.2018-0430. doi: 10.1634/theoncologist.2018-0430. [Epub ahead of print]

PMID:
30659078
2.

Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities.

Millis SZ, Jardim DL, Albacker L, Ross JS, Miller VA, Ali SM, Kurzrock R.

Cancer. 2018 Dec 24. doi: 10.1002/cncr.31921. [Epub ahead of print]

PMID:
30582752
3.

The relation between cognitive dysfunction and diffusion tensor imaging parameters in traumatic brain injury.

Hanks R, Millis S, Scott S, Gattu R, O'Hara NB, Haacke M, Kou Z.

Brain Inj. 2018 Dec 19:1-9. doi: 10.1080/02699052.2018.1553073. [Epub ahead of print]

PMID:
30563361
4.

BRCA1/2 Functional Loss Defines a Targetable Subset in Leiomyosarcoma.

Seligson ND, Kautto EA, Passen EN, Stets C, Toland AE, Millis SZ, Meyer CF, Hays JL, Chen JL.

Oncologist. 2018 Dec 12. pii: theoncologist.2018-0448. doi: 10.1634/theoncologist.2018-0448. [Epub ahead of print]

PMID:
30541756
5.

Outcomes after Concussion Recovery Education: Effects of Litigation and Disability Status on Maintenance of Symptoms.

Hanks RA, Rapport LJ, Seagly K, Millis SR, Scott C, Pearson C.

J Neurotrauma. 2018 Sep 6. doi: 10.1089/neu.2018.5873. [Epub ahead of print]

PMID:
30117361
6.

Cognitive Log performance among individuals without brain injury in an inpatient rehabilitation setting.

McLaughlan JK, Vos L, Waldron-Perrine B, Sherman T, Millis SR.

Rehabil Psychol. 2018 Aug;63(3):479-485. doi: 10.1037/rep0000236.

PMID:
30113203
7.

Genomic Profiling in Patients With Malignant Peripheral Nerve Sheath Tumors Reveals Multiple Pathways With Targetable Mutations.

Kaplan HG, Rostad S, Ross JS, Ali SM, Millis SZ.

J Natl Compr Canc Netw. 2018 Aug;16(8):967-974. doi: 10.6004/jnccn.2018.7033.

PMID:
30099373
8.

Genomic Characterization of Testicular Germ Cell Tumors Relapsing After Chemotherapy.

Necchi A, Bratslavsky G, Corona RJ, Chung JH, Millis SZ, Elvin JA, Vergilio JA, Suh J, Ramkissoon S, Severson E, Daniel S, Killian JK, Ali SM, Schrock AB, Reddy P, Miller VA, Welsh A, Gay LM, Ross JS.

Eur Urol Focus. 2018 Jul 16. pii: S2405-4569(18)30179-2. doi: 10.1016/j.euf.2018.07.013. [Epub ahead of print]

PMID:
30025711
9.

Response to Checkpoint Inhibitor Therapy in Advanced Classic Kaposi Sarcoma: A Case Report and Immunogenomic Study.

Saller J, Walko CM, Millis SZ, Henderson-Jackson E, Makanji R, Brohl AS.

J Natl Compr Canc Netw. 2018 Jul;16(7):797-800. doi: 10.6004/jnccn.2018.7018.

PMID:
30006421
10.

Social Competence Treatment After Traumatic Brain Injury: A Multicenter, Randomized Controlled Trial of Interactive Group Treatment Versus Noninteractive Treatment.

Harrison-Felix C, Newman JK, Hawley L, Morey C, Ketchum JM, Walker WC, Bell KR, Millis SR, Braden C, Malec J, Hammond FM, Eagye CB, Howe L.

Arch Phys Med Rehabil. 2018 Nov;99(11):2131-2142. doi: 10.1016/j.apmr.2018.05.030. Epub 2018 Jun 30.

PMID:
29966645
11.

MRI and Neuropsychological Correlates in African Americans With Hypertension and Left Ventricular Hypertrophy.

Waldron-Perrine B, Kisser JE, Brody A, Haacke EM, Dawood R, Millis S, Levy P.

Am J Hypertens. 2018 Jul 16;31(8):865-868. doi: 10.1093/ajh/hpy060.

PMID:
29672672
12.

A Chemical-Biological-Radio-Nuclear (CBRN) Filter can be Added to the Air-Outflow Port of a Ventilator to Protect a Home Ventilated Patient From Inhalation of Toxic Industrial Compounds.

Be'eri E, Owen S, Beeri M, Millis SR, Eisenkraft A.

Disaster Med Public Health Prep. 2018 Dec;12(6):739-743. doi: 10.1017/dmp.2018.3. Epub 2018 Feb 21.

PMID:
29463330
13.

Safety and effectiveness of high-dose, weight-based factor VIII inhibitor bypassing activity for warfarin-induced life-threatening bleeding.

Messana EA, Saely S, Millis SR, Levy PD.

Blood Coagul Fibrinolysis. 2018 Mar;29(2):205-210. doi: 10.1097/MBC.0000000000000705.

PMID:
29369079
14.

Predictors of readmission to acute care during inpatient rehabilitation for non-traumatic spinal cord injury.

Robinson DM, Bazzi MS, Millis SR, Bitar AA.

J Spinal Cord Med. 2018 Jul;41(4):444-449. doi: 10.1080/10790268.2018.1426235. Epub 2018 Jan 22.

PMID:
29355465
15.

Emergency department visits in patients with low acuity conditions: Factors associated with resource utilization.

Pearson C, Kim DS, Mika VH, Imran Ayaz S, Millis SR, Dunne R, Levy PD.

Am J Emerg Med. 2018 Aug;36(8):1327-1331. doi: 10.1016/j.ajem.2017.12.033. Epub 2017 Dec 13.

PMID:
29277493
16.

Comprehensive Genomic Sequencing of Urothelial Tumors Identifies Rare SMARCB1 (INI-1)-Deficient Carcinomas of the Urinary System.

Gupta S, Albertson D, Gaston D, Heilbrun ME, Agarwal N, Boucher K, Parnell TJ, Liu T, Morgans A, Madison R, Gowen K, Miller VA, Ross JS, Ali SM, Millis SZ.

Clin Genitourin Cancer. 2018 Apr;16(2):e373-e382. doi: 10.1016/j.clgc.2017.09.001. Epub 2017 Sep 7.

PMID:
28974397
17.

Blood pressure variability as an indicator of sepsis severity in adult emergency department patients.

Nouriel JE, Millis SR, Ottolini J, Wilburn JM, Sherwin RL, Paxton JH.

Am J Emerg Med. 2018 Apr;36(4):560-566. doi: 10.1016/j.ajem.2017.09.017. Epub 2017 Sep 14.

PMID:
28967450
18.

Next-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability.

Bieg-Bourne CC, Millis SZ, Piccioni DE, Fanta PT, Goldberg ME, Chmielecki J, Parker BA, Kurzrock R.

Cancer Res. 2017 Nov 15;77(22):6313-6320. doi: 10.1158/0008-5472.CAN-17-1569. Epub 2017 Sep 22.

19.

Clinical Benefit from Trametinib in a Patient with Appendiceal Adenocarcinoma with a GNAS R201H Mutation.

Ang C, Stollman A, Zhu H, Sarpel U, Scarborough B, Sahni G, Millis SZ.

Case Rep Oncol. 2017 Jun 22;10(2):548-552. doi: 10.1159/000477562. eCollection 2017 May-Aug.

20.

Hemodynamic characteristics of suspected stroke in the emergency department.

Miller JB, Nowak RM, Reed BP, DiSomma S, Nanayakkara P, Moyer M, Millis S, Kinni H, Levy P.

Am J Emerg Med. 2017 Dec;35(12):1915-1918. doi: 10.1016/j.ajem.2017.08.017. Epub 2017 Aug 8.

PMID:
28811213
21.

Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer.

Abbosh P, Sundararajan S, Millis SZ, Hauben A, Reddy S, Geynisman DM, Uzzo R.

Eur Urol Focus. 2018 Dec;4(6):969-971. doi: 10.1016/j.euf.2017.01.003. Epub 2017 Jan 23.

PMID:
28753842
22.

Molecular Characterization of Bladder Cancer in Smokers versus Nonsmokers.

Joshi M, Millis SZ, Arguello D, Holder SL, Lamm D, Reddy S, Belani C, Drabick JJ, Vogelzang NJ.

Eur Urol Focus. 2018 Jan;4(1):94-97. doi: 10.1016/j.euf.2016.06.011. Epub 2016 Jun 24.

23.

Cerebrospinal fluid humoral immunity in the differential diagnosis of multiple sclerosis.

Bernitsas E, Khan O, Razmjou S, Tselis A, Bao F, Caon C, Millis S, Seraji-Bozorgzad N.

PLoS One. 2017 Jul 20;12(7):e0181431. doi: 10.1371/journal.pone.0181431. eCollection 2017.

24.

Cerebral Gray Matter Atrophy Is Associated with the CSF IgG index in African American with Multiple Sclerosis.

Seraji-Bozorgzad N, Khan O, Cree BAC, Bao F, Caon C, Zak I, Razmjou S, Tselis A, Millis S, Bernitsas E.

J Neuroimaging. 2017 Sep;27(5):476-480. doi: 10.1111/jon.12435. Epub 2017 Mar 29.

PMID:
28371088
25.

Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis.

Borazanci E, Millis SZ, Kimbrough J, Doll N, Von Hoff D, Ramanathan RK.

J Gastrointest Oncol. 2017 Feb;8(1):164-172. doi: 10.21037/jgo.2017.01.14.

26.

Rasch analysis of alcohol abuse and dependence diagnostic criteria in persons with spinal cord injury.

Reslan S, Kalpakjian CZ, Hanks RA, Millis SR, Bombardier CH.

Spinal Cord. 2017 May;55(5):497-501. doi: 10.1038/sc.2016.146. Epub 2017 Feb 28.

PMID:
28244502
27.

Intravenous enalaprilat for treatment of acute hypertensive heart failure in the emergency department.

Ayaz SI, Sharkey CM, Kwiatkowski GM, Wilson SS, John RS, Tolomello R, Mahajan A, Millis S, Levy PD.

Int J Emerg Med. 2016 Dec;9(1):28. doi: 10.1186/s12245-016-0125-4. Epub 2016 Dec 28.

28.

Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury.

Welch RD, Ellis M, Lewis LM, Ayaz SI, Mika VH, Millis S, Papa L.

J Neurotrauma. 2017 Jun 1;34(11):1957-1971. doi: 10.1089/neu.2016.4772. Epub 2017 Feb 27.

PMID:
28031000
29.

Presenting phenotypes of acute heart failure patients in the ED: Identification and implications.

Nowak RM, Reed BP, DiSomma S, Nanayakkara P, Moyer M, Millis S, Levy P.

Am J Emerg Med. 2017 Apr;35(4):536-542. doi: 10.1016/j.ajem.2016.12.003. Epub 2016 Dec 8.

PMID:
27986335
30.

Use of nitroglycerin by bolus prevents intensive care unit admission in patients with acute hypertensive heart failure.

Wilson SS, Kwiatkowski GM, Millis SR, Purakal JD, Mahajan AP, Levy PD.

Am J Emerg Med. 2017 Jan;35(1):126-131. doi: 10.1016/j.ajem.2016.10.038. Epub 2016 Oct 18.

PMID:
27825693
31.

Survey of Emergency Physician Approaches to Management of Asymptomatic Hypertension.

Brody A, Twiner M, Kumar A, Goldberg E, McNaughton C, Souffront K, Millis S, Levy PD.

J Clin Hypertens (Greenwich). 2017 Mar;19(3):265-269. doi: 10.1111/jch.12921. Epub 2016 Sep 28.

32.

Barriers to emergency physician diagnosis and treatment of uncontrolled chronic hypertension.

Brody AM, Sharma VK, Singh A, Kumar VA, Goldberg EM, Millis SR, Levy PD.

Am J Emerg Med. 2016 Nov;34(11):2241-2242. doi: 10.1016/j.ajem.2016.08.050. Epub 2016 Aug 27. No abstract available.

PMID:
27623082
33.

Presenting hemodynamic phenotypes in ED patients with confirmed sepsis.

Nowak RM, Reed BP, Nanayakkara P, DiSomma S, Moyer ML, Millis S, Levy P.

Am J Emerg Med. 2016 Dec;34(12):2291-2297. doi: 10.1016/j.ajem.2016.08.031. Epub 2016 Aug 16.

PMID:
27613360
34.

Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors.

Millis SZ, Ikeda S, Reddy S, Gatalica Z, Kurzrock R.

JAMA Oncol. 2016 Dec 1;2(12):1565-1573. doi: 10.1001/jamaoncol.2016.0891.

PMID:
27388585
35.

Prevalence of below-criterion Reliable Digit Span scores in a clinical sample of older adults.

Zenisek R, Millis SR, Banks SJ, Miller JB.

Arch Clin Neuropsychol. 2016 Aug;31(5):426-33. doi: 10.1093/arclin/acw025. Epub 2016 May 8.

36.

Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials.

Friedlander ML, Russell K, Millis S, Gatalica Z, Bender R, Voss A.

Int J Gynecol Cancer. 2016 May;26(4):648-54. doi: 10.1097/IGC.0000000000000677.

37.

Correlates of resilience in the first 5 years after traumatic brain injury.

Hanks RA, Rapport LJ, Waldron Perrine B, Millis SR.

Rehabil Psychol. 2016 Aug;61(3):269-276. doi: 10.1037/rep0000069. Epub 2016 Feb 8.

PMID:
26855130
38.

Delegates view deployable military hospital.

Millis S.

Nurs N Z. 2015 Nov;21(10):33. No abstract available.

PMID:
26717634
39.

Molecular Profiling of Refractory Adrenocortical Cancers and Predictive Biomarkers to Therapy.

Millis SZ, Ejadi S, Demeure MJ.

Biomark Cancer. 2015 Dec 17;7:69-76. doi: 10.4137/BIC.S34292. eCollection 2015.

40.

Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options.

Ang C, Miura JT, Gamblin TC, He R, Xiu J, Millis SZ, Gatalica Z, Reddy SK, Yee NS, Abou-Alfa GK.

J Surg Oncol. 2016 Jan;113(1):55-61. doi: 10.1002/jso.24086. Epub 2015 Dec 10.

PMID:
26661118
41.

Characterization of Human Rib Biomechanical Responses due to Three-Point Bending.

Kalra A, Saif T, Shen M, Jin X, Zhu F, Begeman P, Yang KH, Millis S.

Stapp Car Crash J. 2015 Nov;59:113-30.

PMID:
26660742
42.

Adenosquamous carcinoma of the pancreas: Molecular characterization of 23 patients along with a literature review.

Borazanci E, Millis SZ, Korn R, Han H, Whatcott CJ, Gatalica Z, Barrett MT, Cridebring D, Von Hoff DD.

World J Gastrointest Oncol. 2015 Sep 15;7(9):132-40. doi: 10.4251/wjgo.v7.i9.132. Review.

43.

Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers.

Wen W, Chen WS, Xiao N, Bender R, Ghazalpour A, Tan Z, Swensen J, Millis SZ, Basu G, Gatalica Z, Press MF.

J Mol Diagn. 2015 Sep;17(5):487-95. doi: 10.1016/j.jmoldx.2015.04.003.

44.

PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation.

Joseph RW, Millis SZ, Carballido EM, Bryant D, Gatalica Z, Reddy S, Bryce AH, Vogelzang NJ, Stanton ML, Castle EP, Ho TH.

Cancer Immunol Res. 2015 Dec;3(12):1303-7. doi: 10.1158/2326-6066.CIR-15-0150. Epub 2015 Aug 25.

45.

In response: Naming and recognition after laser amygdalohippocampotomy: Is the hippocampus involved?

Drane DL, Loring DW, Voets NL, Price M, Ojemann JG, Willie JT, Saindane AM, Phatak V, Ivanisevic M, Millis S, Helmers SL, Miller JW, Meador KJ, Gross RE.

Epilepsia. 2015 Aug;56(8):1318-9. doi: 10.1111/epi.13065. No abstract available.

46.

Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.

Gatalica Z, Bilalovic N, Palazzo JP, Bender RP, Swensen J, Millis SZ, Vranic S, Von Hoff D, Arceci RJ.

Oncotarget. 2015 Aug 14;6(23):19819-25.

47.

Predictive Biomarker Profiling of > 6000 Breast Cancer Patients Shows Heterogeneity in TNBC, With Treatment Implications.

Millis SZ, Gatalica Z, Winkler J, Vranic S, Kimbrough J, Reddy S, O'Shaughnessy JA.

Clin Breast Cancer. 2015 Dec;15(6):473-481.e3. doi: 10.1016/j.clbc.2015.04.008. Epub 2015 Apr 28.

48.

Multi-platform profiling of over 2000 sarcomas: identification of biomarkers and novel therapeutic targets.

Movva S, Wen W, Chen W, Millis SZ, Gatalica Z, Reddy S, von Mehren M, Van Tine BA.

Oncotarget. 2015 May 20;6(14):12234-47.

49.

Safety and efficacy of antihypertensive prescription at emergency department discharge.

Brody A, Rahman T, Reed B, Millis S, Ference B, Flack JM, Levy PD.

Acad Emerg Med. 2015 May;22(5):632-5. doi: 10.1111/acem.12660. Epub 2015 Apr 22.

50.

Spinal cord atrophy in multiple sclerosis and relationship with disability across clinical phenotypes.

Bernitsas E, Bao F, Seraji-Bozorgzad N, Chorostecki J, Santiago C, Tselis A, Caon C, Zak I, Millis S, Khan O.

Mult Scler Relat Disord. 2015 Jan;4(1):47-51. doi: 10.1016/j.msard.2014.11.002. Epub 2014 Nov 18.

PMID:
25787052

Supplemental Content

Loading ...
Support Center